GT Biopharma Inc (GTBP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.67M
Last updated: Nov 17, 2026 at 4:42 PM ET
GT Biopharma Inc (GTBP) Stock Chart
GT Biopharma (GTBP) has a latest price of $3.18 on Nov 17, 2026. Its price fell 86.2% over the past 12 months. The month-end price fell 100.0% since Sep 2017, a compound annual decline of 64.5%.
Price Chart
From Sep 2017 to Oct 2026, its highest month-end close was $75,330.43 in Oct 2017 and its lowest $5.32 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GTBP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GTBP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 55.7%, and over 6 months it fell 70.4%. The month-end price fell 97.2% over the 3 years through Oct 2026, a compound annual decline of 69.5%.
| Period | Change |
|---|---|
| 1 month | -52.5% |
| 3 months | -55.7% |
| 6 months | -70.4% |
| 12 months | -86.2% |
| 12 months, with dividends | -86.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -97.2% | -69.5% |
| 5 years | -99.9% | -74.4% |
| Since Sep 2017 | -100.0% | -64.5% |
Price by Year
Its best calendar year was 2020, when the price rose 423.5%, and its weakest was 2019, when it fell 87.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $5.32 | -72.9% |
| 2025 | $19.63 | -74.3% |
| 2024 | $76.25 | -60.2% |
| 2023 | $191.44 | -71.2% |
| 2022 | $664.94 | -71.0% |
| 2021 | $2,289.79 | -57.7% |
| 2020 | $5,413.58 | +423.5% |
| 2019 | $1,034.20 | -87.5% |
| 2018 | $8,299.12 | -85.4% |
Trading Range
The price is 47.9% below its 50-day average of $6.10 and 64.5% below its 200-day average of $8.96.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.18 | |
| 50-day average | $6.10 | -47.9% |
| 200-day average | $8.96 | -64.5% |
Price Risk
Over 3 years, its largest fall from a peak was 98.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.35 |
| Largest fall, 1 year | -86.2% |
| Largest fall, 3 years | -98.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GTBP
What is GTBP's 1-year price change?
GT Biopharma's price fell 86.2% over the past 12 months. With dividends included, the 12-month total return was -86.2%.
What is GTBP's 5-year price change?
GT Biopharma's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 74.4%. These figures leave out dividends.
What is GTBP's beta?
GT Biopharma's 1-year beta against the S&P 500 is 1.35, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 86.2%.
Is the GTBP chart free?
Yes. Advanced Charting for GTBP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GTBP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors